HOME >> MEDICINE >> NEWS
Experimental pill found to improve symptoms in patients with non-small-cell lung cancer

ORLANDO, FLA. (May 19, 2002, 12:00 p.m., EST) An experimental pill has been found to improve symptoms and quality of life in patients with non-small-cell lung cancer, according to research findings presented by Ronald B. Natale, M.D., Acting Medical Director at Cedars-Sinai Comprehensive Cancer Center, and lead author of the study. The pill, called ZD 1839 (Iressa) is one of a new class of drugs that targets and blocks a key growth signal in cancer cells.

The study, presented at the 38th annual meeting of the American Society of Clinical Oncology (ASCO) in Orlando, Florida, evaluated 216 patients with recurrent non-small-cell lung cancer who had undergone two or more rounds of chemotherapy. One group of patients received 250 mg of ZD 1839 (Iressa) daily, while the second group received ZD 1839 at 500 mg each day until the disease progressed. The investigators found that lung cancer symptoms, such as cough, shortness of breath, chest pain or tightness, appetite and fatigue, were greatly improved in about 40 percent of patients. Further, they found that symptom improvement was associated with a longer survival.

Our results show that patients who felt better after taking ZD 1839, actually lived longer than those whose symptoms did not improve, said Dr. Natale. This is important because it shows that a daily pill reduced symptoms such to the extent that many of our patients were able to resume their normal activities and enjoy life for longer.

ZD 1839 (Iressa), a pill developed by AstraZeneca, has been found to work in both laboratory and clinical trials by targeting and blocking a key growth signaling mechanism in cancer cells called the epidermal growth factor receptor (EGFR). Otherwise known as HER1, the EGFR is a part of the HER kinase family of proteins that control cell growth and can stimulate the spread of cancer when over-expressed on malignant cells.

Non-small-cell lung cancer is the most common type of lung cancer,
'"/>

Contact: Kelli Stauning
kelli.stauning@cshs.org
310-423-3674
Cedars-Sinai Medical Center
19-May-2002


Page: 1 2 3

Related medicine news :

1. St. Jude scientist wins International Society of Experimental Hematology award
2. Experimental drug improves sleep in older patients, Wake Forest Baptist study shows
3. Experimental drug used to treat recurrent ovarian cancer shows promising results
4. Experimental treatment yields new hope for children battling cerebral palsy
5. Experimental drugs show promise in halting brain tumors
6. Experimental drugs reduce neuron death in rats following insulin shock
7. Experimental drug reverses effects of Fabry disease in mice
8. Experimental peptides prevent diabetes and halt its progression
9. Experimental testosterone patch shows promise for treating diminished sexual function in surgically menopausal women
10. Clinical Trial Demonstrates Experimental Growth Factor Increases Eligibility For Autologous Stem Cell Transplantation
11. Acupuncture found to lower elevations in blood pressure

Post Your Comments:
(Date:5/5/2015)... Pittsburgh, Pa (PRWEB) May 05, 2015 ... signs of accelerated aging that correlate with slower information ... of Pittsburgh Graduate School of Public Health . ... middle-aged patients with type 1 diabetes for cognitive difficulties. ... manage their diabetes. The study, funded by the ...
(Date:5/5/2015)... On May, 5, 2015, My Positive Perspective host Jason Deierlein ... for youngsters to do this summer. As the episode began, ... starting a summer camp and how is it going to ... Upon a Party and I come to children’s birthday parties ... We play games, sing, and dance and have a great ...
(Date:5/5/2015)... CA (PRWEB) May 05, 2015 ... ahead, Josie's Organics, one of the country's leading ... the minds of moms across the country. What ... the family recipe box or spend hours browsing ... today on http://www.josiesorganics.com/recipes . , The ...
(Date:5/5/2015)... Don’t have time to go to the gym? ... know which workout equipment to use? LiveStreamingFitness.com now ... members achieve their heath and fitness goals and live ... wellness company, today announces the launch of LiveStreamingFitness.com, a ... certified trainers, nutritional information and recipes provided by an ...
(Date:5/5/2015)... 05, 2015 Sheltering Arms held its ... “Clyde” Frazier and Cravath, Swaine & Moore LLP for ... communities. The event was co-chaired by Vanguard sponsors Morgan ... Next Chapter” highlighted Sheltering Arms’ significant growth in New ... in February 2015. Formerly Episcopal Social Services, Sheltering Arms ...
Breaking Medicine News(10 mins):Health News:Accelerated Brain Aging in Type 1 Diabetes Related to Cognitive Complications 2Health News:Accelerated Brain Aging in Type 1 Diabetes Related to Cognitive Complications 3Health News:Accelerated Brain Aging in Type 1 Diabetes Related to Cognitive Complications 4Health News:My Positive Perspective Hosts Episode Informing People of a True Princess Summer Camp With Irene Rose 2Health News:Josie's Organics Kicks Off Mother's Day, Graduation and Grilling Season with New, Easy-to-Follow, Convenient Recipes 2Health News:Josie's Organics Kicks Off Mother's Day, Graduation and Grilling Season with New, Easy-to-Follow, Convenient Recipes 3Health News:Josie's Organics Kicks Off Mother's Day, Graduation and Grilling Season with New, Easy-to-Follow, Convenient Recipes 4Health News:Live Streaming Fitness Creates Industry Shift by Bringing Fitness, Nutrition and Cooking Classes to Smart Devices 2Health News:Live Streaming Fitness Creates Industry Shift by Bringing Fitness, Nutrition and Cooking Classes to Smart Devices 3Health News:Sheltering Arms Honors Walt "Clyde" Frazier and Cravath, Swaine & Moore LLP at Annual Gala 2
(Date:5/5/2015)... 2015  Stryker Orthopaedics announced today its return to ...  Since becoming the "Official Joint Replacement Products ... year ago, the company has made 14 stops along ... onsite activation the Stryker Mobility Zone – a destination ... joint health. Proving to be a successful program, Stryker ...
(Date:5/5/2015)... May 5, 2015 Omeros Corporation (NASDAQ: ... discovering, developing and commercializing both small-molecule and protein ... targeting inflammation, coagulopathies and disorders of the central ... issue its first quarter 2015 financial results for ... May 11, 2015, after market close. Omeros management ...
(Date:5/5/2015)... 05, 2015 Research and Markets ( ... "Will Theranos Turn the Lab Industry Upside Down?" ... much praise along with a healthy dose of skepticism ... their potentially disruptive laboratory solution. Behind all of the ... Theranos scaled microfluidic technology across a comprehensive menu of ...
Breaking Medicine Technology:Stryker Returns to TPC Sawgrass for THE PLAYERS Championship Alongside Former Tournament Winners Fred Funk and Hal Sutton 2Stryker Returns to TPC Sawgrass for THE PLAYERS Championship Alongside Former Tournament Winners Fred Funk and Hal Sutton 3Omeros Corporation to Announce First Quarter 2015 Financial Results on May 11, 2015 2Will Theranos Turn the Lab Industry Upside Down? 2
Cached News: